CCNB2 and hepatocellular carcinoma: Recent evidence reveals that DLEU2 (Deleted In Lymphocytic Leukemia 2) and HBx cooperate to activate the transcription of CCNB2 in HBV-replicating HCC cells [69], offering a confirmation in the role of CCNB2 in HBV-HCC.